Results 171 to 180 of about 254,610 (274)
ESC Heart Failure, EarlyView.Abstract Background The optimal strategy for modern chemotherapy should be based on a comprehensive approach for cancer patients with cardiovascular diseases. Therefore, cardio‐oncology has received increasing attention owing to the cardiotoxic effects of anti‐cancer therapies.
Tomiko Sunaga +7 more
wiley +1 more source
Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer. [PDF]
Cancers (Basel)Jager EC +6 more
europepmc +1 more source
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. [PDF]
, 1992 Massimo Santoro +9 more
openalex +1 more source
Identification of thyroid cancer biomarkers using WGCNA and machine learning. [PDF]
Eur J Med ResHu G +9 more
europepmc +1 more source
Thyroid dysfunction associated with immunotherapy for patients with cancer [PDF]
, 1991 Douglas J. Schwartzentruber +4 more
openalex +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Heart failure represents a substantial burden to both patients and healthcare systems worldwide. Nitric oxide (NO) dysregulation may play a key role in patients transitioning from chronic to acute heart failure with a reduced ejection fraction (HFrEF). Plasma nitrite (NO2−) is highly reflective of local nitric oxide production and has not
Roman Falls +3 more
wiley +1 more source
Comprehensive Treatment of Anaplastic Thyroid Cancer: A Case Report. [PDF]
Onco Targets TherLiu J, Chu J.
europepmc +1 more source
The association of body size, reproductive factors and thyroid cancer [PDF]
, 1992 Marc T. Goodman, LN Kolonel, LR Wilkens
openalex +1 more source
Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort study
European Journal of Heart Failure, EarlyView.Time of diagnosis of comorbidities in relation to heart failure. COPD, chronic obstructive pulmonary disease; MI, myocardial infarction. Abstract Aims Heart failure (HF) is frequently associated with multiple comorbidities. We aimed to define their trajectory of accrual to identify opportunities for disease prevention. Methods and results We identified
Hugo MacGowan +12 more
wiley +1 more source
Journal of Bone and Mineral Research, Volume 38, Issue 1, Page 14-25, January 2023., 2023 TransCon PTH is an investigational once‐daily prodrug providing sustained release of active PTH designed to maintain stable PTH levels in the physiological range for 24 hours/day. The PaTHway trial met all primary and key secondary endpoints with statistically significant differences from placebo. Most adverse events (AEs) were mild/moderate. Injection‐
Aliya A Khan +19 more
wiley +1 more source